Resource Support Program for AIDS Vaccine Development
Award Notice Posted
- Solicitation number
- 75N93025C00011
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Quality Biological Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93025C00011 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Gaithersburg, Maryland 20879, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, has awarded a contract to Quality Biological, Inc. for the Resource Support Program for AIDS Vaccine Development, valued at $25,374,525. The contract, which runs from April 8, 2025, through April 7, 2032, will provide critical research support services for AIDS vaccine development, including generating overlapping peptide sets for Simian and Human Immunodeficiency Viruses, producing polyclonal and monoclonal antibodies, and providing SIV and SHIV challenge stocks. These services will support NIAID-funded grantees, other NIH-funded researchers, and Non-Governmental Organizations involved in AIDS vaccine research, complementing the existing NIH HIV Reagent Program by supplying targeted reagents, assays, and services to investigators in the field.
Notice text
The discovery and development of an Acquired Immune Deficiency Syndrome (AIDS) vaccine remains among the highest research priorities of the National Institute of Allergy and Infectious Diseases (NIAID) and is a principal mission of NIAID’s Division of AIDS (DAIDS). To support this mission, NIAID has provided high-quality, novel, and targeted reagents, assays and services for investigators engaged in AIDS vaccine-related research, including NIAID funded grantees and contractors, other NIH-funded researchers, and investigators supported through various Non-Governmental Organizations (NGOs). Supported contractors include the DAIDS Simian Vaccine Evaluation Units (SVEUs) and their support contractors. These services are provided through this contract by investigator request to NIAID and NIAID staff approval. The incumbent contractor is Quality Biological, Inc.(HHSN272201800007C). Services provided under the current contract have included providing overlapping peptide sets for Simian Immuno-deficiency Virus/Simian Human Immuno-deficiency Virus (SIV/SHIV) and Human Immuno-deficiency Virus (HIV), polyclonal and monoclonal antibodies, SIV and SHIV challenge stocks, and storage and shipping of kits for proficiency testing/standardization for neutralization assays (TZM-bl neutralization assay). The Resource Support Program for AIDS Vaccine Development contract complements the “NIH HIV Reagent Program” (www.hivreagentprogram.org/) which supplies a larger variety of reagents to both vaccine and non-vaccine AIDS researchers as well.
Awarded contract 75N93025C00011 to Quality Biological, Inc for 25374525.00 on 2025-04-08.
Files
| File | Type | Posted |
|---|---|---|
| Award Synopsis.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Resource Support Program for AIDS Vaccine Development | Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity